A survey of diabetes educators reveals challenges faced by patients with diabetes who can’t afford their drugs.
A new survey of professional diabetes educators shows that patients with diabetes struggle to afford their medications and are seeking relief on many levels including using discount prescription savings cards in order to better manage their condition.
Professional diabetes educators credentialed in diabetes self-management training reported that when talking with people under their care, the concerns about affordability of medications and supplies are greater (60%) than concerns their patients voiced over their ability to manage the condition with lifestyle management practices such as maintaining good health and healthy dietary habits.
“When it comes to helping with the cost of affording diabetes medications and insulin, educators take it on themselves to invest the extra time to find ways to help,” says Leslie Achter, CEO for Inside Rx.
According to newly released data, more than half of professional educators polled say they search for discount cards, to cover medication at a price their patient can afford, and 25% of educators, when appropriate, call the physician requesting a change to a generic medication.
Related: Lack Of Public Safe Disposal Options Causes Unease Among Diabetics
The survey also found that nearly two-thirds of educator’s report that their patients admit rationing their medications through actions like cutting their tablets or decreasing their insulin dosage-practices that can be potentially risky and dangerous-making access to discounted medications all the more important.
“Nonadherence is one of the costliest aspects of healthcare,” Achter says. “The cost of prescription medications can affect adherence, particularly among people who are uninsured. For these people and those in high deductible plans, providing access to needed medications at a discounted rate is part of our corporate responsibility as healthcare providers.”
As it relates to this study, health executives should recognize that access and affordability go hand-in-hand as the biggest barriers to a patient successfully managing their diabetes, according to Achter. “This in turn can then lead to non-adherence and overall poor health habits,” she says.
Patients Express Concerns Over Costs, Risks of Gene Therapies for Sickle Cell Disease
December 12th 2024Research at the annual meeting of the American Society of Hematology evaluated patient and caregiver perspectives on gene therapies for sickle cell disease, which offer great potential but have had slow uptake.
Read More
Jack Linehan of Epstein Becker Green Discusses Drug Coupons, Accumulators
July 9th 2020In this week's episode of Tuning Into The C-Suite podcast, Senior Editor Peter Wehrwein has a conversation with John "Jack" Linehan, a lawyer for Epstein Becker Green, about coupons and accumulators. Jack is an expert on drug distribution and reimbursement, and few people know as much about coupons and accumulators as he does. Peter and Jack go over some of the basics, who is advantaged and disadvantaged, and then dive into some the details on CMS regulations and how recent proposed changes to Medicaid best price rules would, if finalized, affect coupons and accumulators.
Listen
Diabetes Management & Telehealth with Leslie Kolb
June 11th 2020Association of Diabetes Care and Education Specialists, chief science and practice officer, Leslie Kolb chats with MHE Associate Editor Briana Contreras in MHE's newest podcast Tuning into the C-Suite about diabetes management and how it's affected by the use of telehealth, especially during the current and trying times of the COVID-19 pandemic.
Listen